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Background
Monoclonal antibody (Mab) production by mammalian
cells is a complex, multiple-step process which is regu-
lated at transcriptional, translational, and post-transla-
tional levels. A detailed understanding of how cells
regulate this pathway is a prerequisite for designing
genetic strategies for increasing antibody production [1].
Methotrexate (MTX), which is widely used in the creation
of high-producing stable cell lines by amplification of
gene copy number, provides an effective means to alter
Mab production rates for mechanistic studies of the regu-
lation of this pathway [2].
Results
In this work, stable CHO DG44 cell lines expressing a
human anti-D Mab were created and single-cell clones
were amplified to obtain a series of cultures with varying
production rates. During the course of amplification,
changes in the Mab gene copy numbers, transcriptional
levels of Mab mRNAs, and accumulated intracellular Mab
peptides were examined for each clone. In addition,
changes in expression levels of representative genes with
function in translation, folding, assembly, and degrada-
tion were determined. Gene copy number and transcrip-
tion level were quantified by quantitative real time PCR,
and the intracellular Mab peptides were quantified by
western blotting and ELISA.
Conclusion
Results obtained in this work could help identify the rate-
limiting steps and factors that are significant in limiting
production rate for high-producing clones.
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